ADMA Biologics Inc
Organization details
- Legal name
- ADMA Biologics Inc
- Former names
- R&R Acquisition VI, Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Ramsey
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ADMA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001368514
- EIN
- 56-2590442
- Wikidata ID
- Q30260263
Board of directors
-
Adam S. Grossman · Director · President and CEOSince 2023
-
Alison Cecily Finger · DirectorSince 2023
-
Bryant Fong · DirectorSince 2023
-
Eduardo Rene Salas · DirectorSince 2024
-
Jerrold B. Grossman · DirectorSince 2023
-
Lawrence P. Guiheen · DirectorSince 2023
-
Martha J. Demski · DirectorSince 2023
-
Steve Elms · DirectorSince 2023
-
Young Kwon · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 2, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.0%
Board connections
2 of this board's directors also sit on 3 other boards. 3 are in the same sector.
-
Alpha Teknova Inc. Same sectorvia Martha J. Demski
-
Equillium Inc. Same sectorvia Martha J. Demski
-
Marker Therapeutics Inc. Same sectorvia Steve Elms
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $468,294
- 5 purchases by 2 insiders
- Sold, last 12 months
- $3,329,430
- 11 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2026 | Adam S. Grossman Director, Officer (President and CEO) | Option exercise | +105,000 | $5.40 | $567,000 |
| Nov 5, 2026 | Adam S. Grossman Director, Officer (President and CEO) | Open-market sale | −105,000 | $12.00 | $1,260,000 |
| Nov 5, 2026 | Adam S. Grossman Director, Officer (President and CEO) | Open-market sale | −42,000 | $12.00 | $504,000 |
| Jul 24, 2026 | Kestenberg-Messina Kaitlin M. Officer (COO and SVP, Compliance) | Shares withheld for tax | −3,177 | $8.37 | $26,591 |
| Jul 16, 2026 | Kohler Terry Officer (CFO and Treasurer) | Grant or award | +85,130 | — | — |
| May 27, 2026 | Jerrold B. Grossman Director | Open-market purchase | +6,400 | $7.91 | $50,624 |
| May 12, 2026 | Jerrold B. Grossman Director | Open-market purchase | +12,500 | $8.01 | $100,125 |
| May 11, 2026 | Jerrold B. Grossman Director | Open-market purchase | +12,500 | $8.01 | $100,125 |
| Apr 1, 2026 | Kestenberg-Messina Kaitlin M. Officer (COO and SVP, Compliance) | Shares withheld for tax | −20,362 | $9.11 | $185,498 |
| Mar 17, 2026 | Lawrence P. Guiheen Director | Gift | −30,000 | — | — |
| Mar 17, 2026 | Lawrence P. Guiheen Director | Gift | +30,000 | — | — |
| Mar 16, 2026 | Adam S. Grossman Director, Officer (President and CEO) | Option exercise | +15,000 | $5.40 | $81,000 |
| Mar 16, 2026 | Adam S. Grossman Director, Officer (President and CEO) | Open-market sale | −15,000 | $15.16 | $227,400 |
| Mar 16, 2026 | Adam S. Grossman Director, Officer (President and CEO) | Open-market sale | −6,000 | $15.16 | $90,960 |
| Mar 13, 2026 | Lawrence P. Guiheen Director | Option exercise | +30,000 | $3.66 | $109,800 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about ADMA Biologics Inc
Who is the CEO of ADMA Biologics Inc?
Adam S. Grossman is ADMA Biologics Inc's President and CEO.
How many directors are on ADMA Biologics Inc's board?
ADMA Biologics Inc's board has 9 directors: Adam S. Grossman, Alison Cecily Finger, Bryant Fong, Eduardo Rene Salas, Jerrold B. Grossman, Lawrence P. Guiheen, Martha J. Demski, Steve Elms and Young Kwon.
Are ADMA Biologics Inc insiders buying or selling shares?
Over the last 12 months, ADMA Biologics Inc insiders bought $468,294 of shares in 5 purchases and sold $3.3 million of shares in 11 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="adma-biologics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.